Value of the combined cytological and cytochemical classification in the management of acute childhood leukemia.
D001856:Bone Marrow Examination; D002648:Child; D002675:Child, Preschool; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006651:Histocytochemistry; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000175:diagnosis; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D010504:Periodic Acid; D010544:Peroxidases; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous; D012189:Retrospective Studies; D013194:Staining and Labeling; D014750:Vincristine / Q000627:therapeutic use
D010504:Periodic Acid; D014750:Vincristine; D015122:Mercaptopurine; D010544:Peroxidases; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin